SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs strong Q3 results and rapid growth in its AI-compute business are driving attention, alongside Musks ambitious expansion outlook. Many traders are bullish on the growth and potential Tesla combination, while others question the forecasts and valuation given heavy spending and cash-burn concerns; merger discussions remain exploratory.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary quarterly outlook sharply exceeded prior guidance, citing stronger AI-platform demand and improved gross margins, driving a rally and renewed enthusiasm for the AI-server business. Many traders see the results as a potential rerating and short-squeeze catalyst, while others remain cautious about cash flow, margin sustainability, and the companys execution record.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

CEO Paul Pragers comments reaffirming strong demand for TeraWulfs power capacity and on-schedule AI data-center construction, along with his distinction between WULFs powered-shell model and GPU-owning neoclouds, have fueled renewed interest and a sharp rebound after a sector selloff. Traders are split on whether the high-volume move signals a lasting reversal or a relief bounce, with financing and execution risks still in focus.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly results beat profit expectations, but softer fourth-quarter guidance and a reduced advertising outlook reignited concerns about slowing growth, weighing on shares. Traders are split between viewing the selloff as an overreaction to a still-profitable business and warning that competition, engagement, and content concerns could keep pressure on the stock.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys upgrade naming Amazon a top pick, citing stronger AWS growth prospects and AI opportunities, has driven attention; the Trainium software push is also viewed as a potential boost to AWS. Traders largely welcomed the rally, while some questioned whether it can hold and whether AI spending will deliver returns ahead of earnings.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Analyst target hikes and expectations for a third-quarter beat and guidance raise are fueling Lillys breakout, with traders pointing to Mounjaro growth outside the U.S. and Zepbound demand tied to Medicare coverage. The mood is broadly bullish, though some traders warn that expectations are priced in and cite valuation and obesity-drug competition as risks.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

The discussion centers on TRUMPs steep decline and volatile trading, with many traders accusing the project of enriching insiders while retail holders absorb losses. Some bullish traders are calling for a rebound or short squeeze, but others expect more downside and dismiss those calls as speculation.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

LUNR is drawing attention amid a steep selloff that traders often link to weakness across space and high-beta stocks, with SpaceXs rise seen by some as pulling capital from competitors. Bears point to dilution, cash burn and a reported earnings miss, while bulls argue the backlog and upcoming NASA milestones could support a recovery.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

The FAAs certification of Boeings 737 MAX 10 is the main catalyst, but traders are split over its significance: some see a long-delayed hurdle cleared, while others call the muted share reaction a sell the news response. Many argue that stronger production and actual deliveriesnot certification alonewill be needed to improve cash flow and build confidence in Boeings turnaround.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grummans quarterly results, raised 2026 outlook and record backlog are driving attention, with traders pointing to strong defense and space demand. The reaction is broadly bullish, though some are watching whether buyers can sustain the post-earnings gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus 

Equity

A combination of the company’s breast cancer drug Etcamah did not delay worsening of the disease enough to meet the SERENA-4 late-stage trial’s main goal, AstraZeneca said. 


NVO Stock Jumps 3% As EU Approves Oral Wegovy Pill — Retail Notes LLY Is ‘Clearly Behind’ Its Danish Counterpart

Oral Wegovy is now cleared in all EU member states.


NVO Stock Gains As UK Clears First Daily GLP-1 Weight-Loss Pill, Offsetting Security Breach News

Novo Nordisk revealed that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Wegovy pill, following in the footsteps of the U.S. FDA. 


AZN Stock Rise As Wall Street Dismisses FDA Committee’s Rejection Of Breast Cancer Drug 

FDA’s Oncologic Drugs Advisory Committee (ODAC) did not reach a majority vote on the benefit-risk profile of AstraZeneca’s camizestrant in combination with other drugs. 

Novo Nordisk Launches Higher Dose Of Wegovy Injection Across US — Retail Thinks Stock Is ‘Terribly Undervalued’

The Wegovy HD injection 7.2 mg will be available through over 70,000 U.S. pharmacies including Novo’s own NovoCare Pharmacy and select telehealth providers, the company said.


Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy

The company stated that Wegovy HD received the FDA’s accelerated approval based on results from the STEP UP trial.

Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock

BMO Capital maintained its ‘Market Perform’ rating for Novo Nordisk, with a price target of $45, implying an upside of more than 13% from NVO stock’s closing price on Monday.

HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy

Hims & Hers also stated that it will no longer advertise compounded GLP-1 offerings on its platform or in its marketing.

Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%

Ozempic and Wegovy will start at a list price of $675 a month, effective Jan. 1, 2027, according to the company.

NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China

Developed in partnership with United Laboratories International Holdings, Novo Nordisk said that UBT251 delivered up to 19.7% mean weight loss after 24 weeks in a phase 2 trial in China.

Putnam ETF Trust - Putnam Focused Large Cap Value ETF

Bearish Sentiment

<ul class="summary-bullets"><li>AstraZeneca, however, said progression-free survival improved numerically.&nbsp;</li><li>Etcamah is a once-daily pill that breaks down the estrogen receptor many breast cancers use to grow and is already approved for a narrower group of breast cancer patients.&nbsp;</li><li>The setback lands on a pipeline already under scrutiny.</li></ul><p>Shares of AstraZeneca traded 3% lower in after-hours trading on Friday after the drugmaker said a large late-stage breast cancer study of Etcamah missed its main goal, denting hopes of a broader first-line use for one of its most closely watched oncology assets.</p><h2 class="st-heading-2">What The Trial Showed</h2><p>The trial SERENA-4 tested Etcamah plus palbociclib against a standard hormone-blocking pill plus palbociclib in 1,371 people starting treatment for advanced hormone-sensitive breast cancer that is not HER2-driven. The Etcamah combination did not delay disease progression enough to meet the trial’s main goal, though AstraZeneca said there was a numerical improvement. Side effects were in line with what is already known for both drugs. The company said it will present full results later.</p><p>Etcamah is a once-daily pill that breaks down the estrogen receptor many breast cancers use to grow. It is already approved in the United States, Europe, Japan and other markets for a narrower group: patients whose tumors pick up a common resistance mutation called ESR1 while they are on first-line hormone therapy. That use is based on an earlier SERENA-6 trial.</p><p>Friday’s miss undercuts the case for giving the drug to all newly diagnosed advanced patients from the start, before that mutation appears.</p><h2 class="st-heading-2">Another Hit After A Rough Year</h2><p>The setback lands on a pipeline already under scrutiny. In July, AstraZeneca’s heart drug Wainua failed a major heart-disease trial, triggering a steep one-day drop. Rare-disease medicine Ultomiris also missed a rare-disease study. In August, AstraZeneca halted a late-stage lung cancer trial of volrustomig after an independent committee said it was unlikely to beat standard immunotherapy.</p><p>Those blows have helped drag the stock down about 20% over six months even as core cancer sales remain a pillar of the business.</p><p>Oncology accounts for a large share of AstraZeneca’s growth. Without a broad first-line label in advanced disease, Etcamah’s near-term commercial reach is smaller. Oncology research chief Susan Galbraith called SERENA-4 disappointing but said the company remains confident in the drug’s longer-term potential in early breast cancer.</p><p>Two separate large trials, CAMBRIA-1 and CAMBRIA-2, are testing Etcamah after surgery in about 10,000 patients to see if it can cut the risk of recurrence.</p><h2 class="st-heading-2">How Did AZN Retail Traders React?</h2><p>On Stocktwits, retail sentiment around AZN stock stayed in ‘bearish’ territory over the past 24 hours, while message volume was ‘high.’</p><p><a href="https://stocktwits.com/symbol/AZN">AZN stock</a> has fallen 9% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/exel-stock-slides-after-fda-adds-three-months-to-cancer-drug-review-william-blair-sees-more-swings-in-near-term/cZtXM0eRBbg">EXEL Stock Slides After FDA Adds Three Months To Cancer Drug Review — William Blair Sees More Swings In Near Term</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

The international biopharmaceutical company Astrazeneca office building in Shanghai, China on June 27, 2025. (Photo credit should read CFOTO/Future Publishing via Getty Images)

A combination of the company’s breast cancer drug Etcamah did not delay worsening of the disease enough to meet the SERENA-4 late-stage trial’s main goal, AstraZeneca said. 

AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus

American Century ETF Trust - Avantis International Equity ETF

AstraZeneca PLC

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

PVAL Putnam ETF Trust - Putnam Focused Large Cap Value ETF

Fundamentals

Latest PVAL News